Hospital Treatment and Supportive Care for La Crosse Encephalitis

When a child is hospitalized with La Crosse encephalitis (LACV), the medical team focuses on supportive care. Because there is currently no “cure,” antibiotic, or FDA-approved antiviral drug for LACV, the goal is to support the body’s vital functions and protect the brain while the immune system fights off the virus ^[1][2].

The Goals of Supportive Care

Supportive care is not “waiting and watching”—it is an active, intensive process of managing the secondary effects of the infection. The immediate priorities in the first 24 to 72 hours include:

• Protecting the Airway: If a child has severe altered mental status (extreme confusion or inability to wake up), they may need help breathing through a ventilator to ensure their brain receives enough oxygen ^[3].
• Managing Brain Swelling: The virus causes inflammation that can lead to cerebral edema (swelling of the brain). To reduce this pressure, doctors may use “hyperosmolar therapy,” such as medications like mannitol or concentrated salt solutions (hypertonic saline), and keep the child’s head elevated ^[4][3].
• Controlling Seizures: Seizures are common in LACV and can cause further brain injury if not stopped ^[5]. Doctors usually start with “rescue” medications like lorazepam to stop an active seizure, followed by long-term maintenance drugs such as levetiracetam, phenytoin, or valproate ^[6].

Why Are There No Specific Treatments?

You may wonder why there isn’t a vaccine or a specific “anti-La Crosse” pill. Developing these is challenging for several reasons:

• Rare Disease Status: Because LACV is relatively rare compared to other viruses, there has historically been less commercial investment in vaccine development ^[1].
• Biological Barriers: Creating a drug that can cross the blood-brain barrier to attack the virus directly without harming delicate brain tissue is technically difficult ^[7].

Investigational Research

While there are no approved treatments today, research is very active. Scientists are exploring:

• CEN Inhibitors: Experimental drugs like CAPCA-1 have shown the ability to block the virus from replicating in laboratory studies ^[2].
• Broad-Spectrum Antivirals: Researchers are testing drugs that target the “entry pathways” the virus uses to get into cells, which might work for multiple types of mosquito-borne viruses ^[8].
• Vaccine Candidates: Several experimental vaccines are in the early “pre-clinical” stages of testing in laboratories ^[9].

The ICU Environment

If your child is in the Pediatric Intensive Care Unit (PICU), they will be closely monitored by a team of specialists, including neurologists (brain doctors) and intensivists (ICU doctors) ^[3]. They use multimodal monitoring, which may include a continuous EEG (a net of wires on the head) to watch for “silent” seizures that have no outward physical signs but can still affect recovery ^[10][11]. Maintaining stable blood pressure, electrolytes, and temperature are all critical parts of this “neuro-protective” care ^[3].

Once stabilized, attention will shift toward identifying and monitoring any long-term effects. You can read about this transition in Life After the Hospital.